Minimally Invasive Retroperitoneal Lymph Node Dissection for Testicular Cancer

Ornob P. Roy, Brian D. Duty, Louis R. Kavoussi

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Testicular cancer is the most common solid organ malignancy in young men between the ages of 15 and 35. Although much of this increase in survival can be attributed to improvements in systemic chemotherapy, surgery retains a critical role in the diagnostic and therapeutic management of testicular cancer. Laparoscopic retroperitoneal lymph node dissection is an effective staging and therapeutic procedure in patients with low-stage testicular cancer. It is an attractive alternative to the open approach, with faster recovery, improved cosmesis, and reduced post-operative morbidity driving its application. In experienced hands, it can be used in postchemotherapy patients.

Original languageEnglish (US)
Pages (from-to)451-458
Number of pages8
JournalUrologic Clinics of North America
Issue number4
StatePublished - Nov 2011
Externally publishedYes


  • Germ cell tumor
  • Laparoscopy
  • Lymph node dissection
  • Retroperitoneal
  • Testicular cancer

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Minimally Invasive Retroperitoneal Lymph Node Dissection for Testicular Cancer'. Together they form a unique fingerprint.

Cite this